Retin-a and Methotrexate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Retin-a (tretinoin) and Methotrexate (methotrexate sodium). Common drug interactions include dental caries among females and anxiety among males.

The phase IV clinical study analyzes what interactions people have when they take Retin-a and Methotrexate. It is created by eHealthMe based on reports of 58 people who take the same drugs from the FDA, and is updated regularly.

What is Retin-a?

Retin-a has active ingredients of tretinoin. It is often used in acne. eHealthMe is studying from 2,475 Retin-a users. Check the latest studies of Retin-a.

What is Methotrexate?

Methotrexate has active ingredients of methotrexate sodium. It is often used in rheumatoid arthritis. eHealthMe is studying from 604,312 Methotrexate users. Check the latest studies of Methotrexate.



On Jul, 09, 2026

58 people who take Retin-a and Methotrexate together, and have interactions are studied.

Retin-a and Methotrexate drug interactions.

What are the common drug interactions of Retin-A and Methotrexate, by gender? *:

female:

  1. Dental caries
  2. Dermatitis contact (skin reaction (dermatitis) resulting from exposure to allergens)
  3. Dry mouth
  4. Dysgeusia (disorder of the sense of taste)
  5. Dysuria (painful or difficult urination)
  6. Gallbladder disorder
  7. Sjogren's syndrome (a disease that causes dryness in the mouth and eyes)
  8. Anaphylactic reaction (serious allergic reaction)
  9. Arthralgia (joint pain)
  10. Headache (pain in head)

male:

  1. Anxiety
  2. Ascites (accumulation of fluid in the abdominal cavity)
  3. Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  4. Muscle spasms (muscle contraction)
  5. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  6. Dizziness
  7. Fall
  8. Head injury
  9. Heart rate decreased
  10. Hyperventilation

What are the common drug interactions of Retin-A and Methotrexate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Anxiety
  2. Ascites (accumulation of fluid in the abdominal cavity)
  3. Dizziness
  4. Fall
  5. Head injury
  6. Heart rate decreased
  7. Hyperventilation
  8. Hypotension (abnormally low blood pressure)
  9. Intra-abdominal haemorrhage (intra-abdominal bleeding)
  10. Loss of consciousness

20-29:

  1. Anal abscess
  2. Biliary dyskinesia (motility disorder that affects the gallbladder and sphincter of oddi)
  3. Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
  4. Gallbladder disorder
  5. Intestinal obstruction
  6. Organ failure

30-39:

  1. Headache (pain in head)
  2. Injection site erythema (redness at injection site)
  3. Injection site pain
  4. Injection site papule (solid pimple or swelling at injection site)
  5. Injection site pruritus (severe itching at injection site)
  6. Meniscus lesion (lesion of a crescent-shaped piece of cartilage between the femur and the tibia)
  7. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  8. Precancerous skin lesion
  9. Procedural pain
  10. Sjogren's syndrome (a disease that causes dryness in the mouth and eyes)

40-49:

n/a

50-59:

  1. Costochondritis (chest wall pain)
  2. Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
  3. Animal scratch
  4. Erythema (redness of the skin)
  5. Localised infection (infection at the single location)
  6. Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  7. Pain in extremity
  8. Peripheral swelling

60+:

  1. Anaphylactic reaction (serious allergic reaction)
  2. Sjogren's syndrome (a disease that causes dryness in the mouth and eyes)
  3. Contusion (a type of hematoma of tissue in which capillaries)
  4. Diarrhoea
  5. Drug hypersensitivity
  6. Dysphagia (a condition in which swallowing is difficult or painful)
  7. Dysphoria (generalized dissatisfaction with life)
  8. Ear pain
  9. Fatigue (feeling of tiredness)
  10. Gait disturbance

What are the existing conditions these people have? *

  1. Dizziness: 40 people, 68.97%
  2. Pain: 15 people, 25.86%
  3. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 4 people, 6.90%
  4. Osteoporosis (bones weak and more likely to break): 3 people, 5.17%
  5. Depression: 3 people, 5.17%

* Approximation only. Some reports may have incomplete information.

Do you take Retin-a and Methotrexate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Retin-a and Methotrexate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Retin-a:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Methotrexate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Retin-a and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Methotrexate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on tretinoin and methotrexate sodium (the active ingredients of Retin-a and Methotrexate, respectively), and Retin-a and Methotrexate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: